MercoPress, en Español
Get our news on your inbox! Suscribe x
Montevideo, January 21st 2019 - 13:56 UTC
Shares in German pharmaceutical group Bayer have dropped sharply following a US verdict linking a product to cancer. By mid-morning on Monday, Bayer's shares had lost 10.4% of their value.
Get our news on your inbox!